Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) Stock Price

SNYStock

$46.02−8.29%52W

Market Cap$110.27B

P/E11.58x

PEG Ratio29.79

Div yield4.12%

Beta0.77

SNY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-13.05%

Price vs S&P 500 (4W)-4.99%

PEG Ratio29.79

VGM Score55.61

P/E Ratio (Annual)11.58x

Indicated Dividend Yield (Annual)4.12%

P/CF (Annual)8.29x

Book Value / Share (Quarterly)$67.41

P/TBV (Annual)2.23x

Indicated Dividend (Annual)$4.81

Revenue Growth (3Y)0.97%

Cash Flow / Share (Quarterly)$6.82

Payout Ratio (TTM)244.95%

Price vs S&P 500 (YTD)-16.28%

Gross Margin (TTM)72.64%

Net Profit Margin (TTM)9.26%

EPS (TTM)$5.37

10-Day Avg Trading Volume1.49M

EPS Excl Extra (TTM)$5.37

Revenue Growth (5Y)4.57%

EPS (Annual)$7.44

Dividend / Share (Annual)$4.53

ROI (Annual)8.52%

Gross Margin (Annual)72.07%

Net Profit Margin (5Y Avg)15.32%

Cash / Share (Quarterly)$6.19

P/E Basic Excl Extra (TTM)16.24x

Revenue Growth QoQ (YoY)10.32%

EPS Growth (5Y)-8.16%

P/E Normalized (Annual)11.58x

ROA (Last FY)6.16%

Revenue Growth TTM (YoY)39.50%

EBITD / Share (TTM)$10.12

ROE (5Y Avg)9.13%

Operating Margin (TTM)13.09%

Cash Flow / Share (Annual)$7.13

P/B Ratio1.31x

P/B Ratio (Quarterly)1.32x

Net Income / Employee (Annual)$119,149

EV / Revenue (TTM)1.79x

Net Interest Coverage (TTM)20.18x

ROA (TTM)4.35%

EPS Growth QoQ (YoY)-65.68%

EV / EBITDA (TTM)10.25x

EPS Incl Extra (Annual)$7.44

Current Ratio (Annual)1.09x

Quick Ratio (Quarterly)0.64x

3-Month Avg Trading Volume2.32M

52-Week Price Return-8.29%

EV / Free Cash Flow (Annual)14.58x

P/E Incl Extra (TTM)16.24x

Revenue / Employee (TTM)$917,835

Tangible BV / Share (Quarterly)$41.74

P/S Ratio (Annual)1.94x

Asset Turnover (Annual)0.37x

52-Week High$106.37

Operating Margin (5Y Avg)18.18%

EPS Excl Extra (Annual)$7.44

CapEx CAGR (5Y)11.18%

Tangible BV CAGR (5Y)0.16%

26-Week Price Return-0.91%

Quick Ratio (Annual)0.70x

13-Week Price Return2.57%

Total Debt / Equity (Annual)0.28x

Current Ratio (Quarterly)0.99x

Enterprise Value$125.57B

Revenue / Share Growth (5Y)5.15%

Asset Turnover (TTM)0.47x

Book Value / Share Growth (5Y)3.22%

Revenue / Employee (Annual)$712,679

Inventory Turnover (Annual)1.33x

Pretax Margin (Annual)13.22%

Cash / Share (Annual)$8.18

3-Month Return Std Dev27.86%

Gross Margin (5Y Avg)70.09%

Net Income / Employee (TTM)$84,957

EBITDA CAGR (5Y)-12.35%

EBITDA Interim CAGR (5Y)-0.54%

ROE (Last FY)10.95%

Net Interest Coverage (Annual)16.92x

EPS Basic Excl Extra (Annual)$7.44

P/FCF (TTM)12.75x

Receivables Turnover (TTM)7.28x

EV / Free Cash Flow (TTM)15.36x

Total Debt / Equity (Quarterly)0.34x

EPS Incl Extra (TTM)$5.37

Receivables Turnover (Annual)5.81x

ROI (TTM)6.03%

Dividend Growth Rate (5Y)4.29%

P/S Ratio (TTM)1.50x

Pretax Margin (5Y Avg)17.25%

Revenue / Share (Annual)$44.48

Tangible BV / Share (Annual)$43.60

Forward P/E8.52x

Free OCF CAGR (5Y)6.70%

Price vs S&P 500 (52W)-28.78%

P/E Ratio (TTM)16.24x

EPS Growth TTM (YoY)-37.36%

Year-to-Date Return-5.37%

5-Day Price Return0.79%

EPS Normalized (Annual)$7.44

ROA (5Y Avg)5.28%

Net Profit Margin (Annual)16.72%

Month-to-Date Return5.12%

Cash Flow / Share (TTM)$10.63

EBITD / Share (Annual)$7.83

EPS Growth (3Y)-1.45%

Operating Margin (Annual)13.58%

LT Debt / Equity (Annual)0.20x

P/CF (TTM)7.64x

ROI (5Y Avg)7.15%

P/E Excl Extra (TTM)16.24x

LT Debt / Equity (Quarterly)0.21x

EPS Basic Excl Extra (TTM)$5.37

P/TBV (Quarterly)2.13x

Payout Ratio (Annual)61.08%

P/B Ratio (Annual)1.41x

Dividend / Share (TTM)$9.37

Inventory Turnover (TTM)1.59x

Pretax Margin (TTM)12.36%

Book Value / Share (Annual)$68.98

Price vs S&P 500 (13W)-0.73%

Net Margin Growth (5Y)-12.66%

Dividend Yield (TTM)10.72%

Beta0.77x

P/FCF (Annual)12.26x

Revenue / Share (TTM)$58.12

ROE (TTM)7.83%

52-Week Low$83.15

vGradeB

gGradeC

mGradeC

vgmGradeC

SNY Earnings Surprise History

Q2 251.06est. 1.17

Q3 251.98est. 1.83

Q4 251.07est. 0.99

Q1 261.29est. 1.20

Q2 261.40est. 1.33

SNY Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.80

3.76

3.77

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$67.01

About Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

Sanofi is a diversified pharmaceutical company focused on immunology, vaccines, and rare diseases. Its flagship product, Dupixent, accounts for approximately 30% of total revenue and is jointly commercialized with Regeneron. The company generates 45% of revenue from the United States, 20% from Europe, and 6% from China.